Imaging Cancer Metabolism with Positron Emission Tomography (PET)
- 7 February 2019
- book chapter
- Published by Springer Nature
- Vol. 1928, 29-44
Abstract
Positron emission tomography (PET) enables the noninvasive spatiotemporal analysis of cancer metabolism in vivo. Both natural and nonnatural PET tracers have been developed to assess metabolic pathways during tumorigenesis, cancer progression, and metastasis. Here we describe the dynamic in vivo PET/CT imaging of the glucose analogue [18F]fluoro-2-deoxy-d-glucose (FDG), taking into consideration the methodology for alternative metabolic PET substrates.Keywords
This publication has 11 references indexed in Scilit:
- Preclinical mouse solid tumour models: status quo, challenges and perspectivesNature Reviews Cancer, 2017
- Guidance for Efficient Small Animal Imaging Quality ControlMolecular Imaging and Biology, 2016
- Imaging Tumor Metabolism Using Positron Emission TomographyThe Cancer Journal, 2015
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2014
- High-throughput multiple-mouse imaging with micro-PET/CT for whole-skeleton assessmentPhysica Medica, 2014
- Late Imaging with [1-11C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PETJournal of Nuclear Medicine, 2014
- Quantitative preclinical PET imaging: opportunities and challengesFrontiers in Physics, 2014
- Standards for PET Image Acquisition and Quantitative Data AnalysisJournal of Nuclear Medicine, 2009
- The Effects of Anesthetic Agent and Carrier Gas on Blood Glucose and Tissue Uptake in Mice Undergoing Dynamic FDG-PET Imaging: Sevoflurane and Isoflurane Compared in Air and in OxygenMolecular Imaging and Biology, 2008
- Anesthesia condition for 18F-FDG imaging of lung metastasis tumors using small animal PETNuclear Medicine and Biology, 2008